About SPR

Father Son Father Son

About SPR

Transforming pain management. Improving patient lives.

At SPR, we are driven by a commitment and passion to improve the lives of millions of people living with pain. Many of us have experienced or seen the lasting impact of pain, and we feel privileged to offer a solution that has helped thousands reclaim their lives. By continuing to pioneer innovative treatments, we aim to offer hope and relief to those who suffer from pain.

Amputee images

We Are SPR™

SPR is an innovative medical device company focused on non-opioid, non-surgical, minimally invasive pain management solutions. Our purpose is clear: to offer proprietary technologies that are used early in the treatment continuum to improve the lives of millions living with acute and chronic pain. We are dedicated to developing and delivering safe, effective treatments that provide meaningful patient outcomes, because we believe patients deserve the opportunity to get back to life — and we’re here to make that happen.

Sprint Device

Our commitment to innovation

Our dedication to patients and pioneering innovative solutions comes to life through our groundbreaking SPR SPRINT® Peripheral Nerve Stimulation (PNS) System — a minimally invasive treatment engineered specifically for the peripheral nervous system. Supported by the largest body of clinical evidence in PNS, multi-million-dollar grants and contracts awarded by the Department of Defense and National Institutes of Health, and countless patient stories demonstrating life-changing relief, the SPRINT PNS System is designed to empower people to reclaim their lives from pain. 

SPR Leadership

Leading with purpose

Our leadership team combines decades of experience in developing and commercializing groundbreaking neurostimulation therapies. With globally recognized leaders in interventional pain management, rehabilitation medicine, orthopedics, and biomedical engineering as our clinical and scientific advisors, we partner with the best in the field to revolutionize pain therapies and improve the lives of even more patients.

Maria Bennett Maria Bennett

“Innovation is at the core of SPR, but it’s innovation with purpose — driven by the real-life stories of people living with pain. Our mission to deliver life-changing results, inspires every team member we hire, every investment we make, and every breakthrough we pursue.”

– Maria Bennett, President, CEO, and Founder of SPR 

Milestones in innovation

Sprint on Pad device Sprint on Pad device

The beginning of a vision

SPR was founded with a clear purpose: to revolutionize pain management. During this period, we secured foundational patents, designed and developed our first-generation SPRINT PNS System, demonstrated safety and efficacy in key pain areas, and laid the groundwork for what would become a trailblazing company in neurostimulation. 

Team Photo Team Photo

Breaking ground with FDA clearance

In 2016, we achieved FDA 510(k) clearance for the first-generation SPRINT PNS System, offering a minimally invasive solution for both acute and chronic pain in the back and/or extremities. This pivotal moment marked the start of our commercial journey.

Group of doctors wearing scrubs Group of doctors wearing scrubs

Building a new market in pain management

The development and clearance of our next-generation single and dual lead SPRINT PNS System propelled us forward, as we embarked on building a new market in peripheral pain with increasing momentum. By 2019, we reached a key milestone—treating our 1,000th patient, validating the unmet need for a non-surgical, non-opioid pain management solution.

Dr Sheth 5,000 implant Dr Sheth 5,000 implant

Increased commercial awareness and adoption

With continued clinical success and an expanded indication allowing for on-label treatment of headache and neck pain, our SPRINT PNS System reached over 5,000 patients by 2021, a testament to its growing impact. To respond to the commercial demand and support our US commercial expansion, SPR closed an oversubscribed growth equity financing. 

70% graphic 70% graphic

Commercial demand and rapid growth

Our commitment to patient outcomes drove us to publish real-world evidence showing pain relief in over 70%  of more than 6,100 patients. With more than 35,000 patients treated and a new FDA clearance in hand, SPR solidified our position as a market leader and continued to expand its reach and influence in the field of pain management.

50,000 implants milestone 50,000 implants milestone

A future of possibilities

Early 2025 proudly marked our 15th anniversary — a significant milestone in our journey of improving lives. In December 2025, we celebrated reaching 50,000 implants of the SPRINT® PNS System, a remarkable achievement that reflects the collaboration and shared commitment of SPR, physicians, and partners to serve patients with compassionate care. Building on this foundation, we continue to develop new products and expand applications, driving innovation that empowers patients to reclaim their lives and embrace brighter futures.    

*Comparison to prior reported implant milestones.